Testing how chemotherapy affects kids’ urinary markers
Part of Cancer, Kidney & urinary clinical trials.
This study looks at urinary (bladder and urine) measurements in children who previously had cancer and were treated with certain chemotherapy drugs. It may help researchers understand how past chemotherapy can affect bladder function and related health markers over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 5 and 13 years old
- Have had a cancer diagnosis in the past
- Have received chemotherapy that included VCR (vincristine) and/or DOX (doxorubicin)
- Have finished chemotherapy at least 1 year before joining and completing surveys
- Do not have a primary tumor in the pelvis
- Do not have had pelvic radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if watching an educational video helps parents and caregivers stick to the treatment plan for children with dysfunctional voiding (trouble emptying the bladder properly). It's for first-time patients who are fully potty-trained and 5 to 18 years old.
This study looks at how well different treatments work for older adults with bladder cancer that has spread and who cannot take cisplatin. It also checks if geriatric assessments help guide care.
This study checks how useful a special test (urethral pressure profile) is for understanding children’s bladder and urine-leakage problems. It may help doctors choose better care by comparing test results in children who have specific bladder conditions versus children without significant symptoms.
This study compares two approaches for people with early-stage bladder cancer that has a low chance of coming back: either careful monitoring without immediate treatment, or receiving chemotherapy directly into the bladder to lower the risk of recurrence. It aims to see if monitoring alone is as good as chemotherapy for those with a low risk detected by a urine test.
This trial checks if a DNA blood test can help decide who needs extra chemo after bladder or upper urinary tract cancer surgery. It tests whether watching for cancer DNA in the blood can match patients to the right treatment.
This trial is testing if a simple urine test can help track prostate or bladder cancer over time without needing invasive procedures. It includes five specific patient groups with different stages of these cancers.
Hear when a new Bladder Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.